117 related articles for article (PubMed ID: 12867010)
41. Adapting clinical trials networks to promote cancer prevention and control research.
Weiner BJ; McKinney MM; Carpenter WR
Cancer; 2006 Jan; 106(1):180-7. PubMed ID: 16333855
[TBL] [Abstract][Full Text] [Related]
42. Publication or presentation of results from multicenter clinical trials: evidence from an academic medical center.
Turer AT; Mahaffey KW; Compton KL; Califf RM; Schulman KA
Am Heart J; 2007 Apr; 153(4):674-80. PubMed ID: 17383311
[TBL] [Abstract][Full Text] [Related]
43. LSU and Tulane suspended from NSABP studies.
J Natl Cancer Inst; 1994 May; 86(10):750-1. PubMed ID: 8169972
[No Abstract] [Full Text] [Related]
44. The clinical site-reading center partnership in clinical trials.
Danis RP
Am J Ophthalmol; 2009 Dec; 148(6):815-7. PubMed ID: 19932801
[No Abstract] [Full Text] [Related]
45. Adverse effects of a multicentre system for ethics approval on the progress of a prospective multicentre trial of cancer treatment: how many patients die waiting?
Christie DR; Gabriel GS; Dear K
Intern Med J; 2007 Oct; 37(10):680-6. PubMed ID: 17894765
[TBL] [Abstract][Full Text] [Related]
46. [Reflexions on clinical trials in Spain].
Betés de Toro M
Med Clin (Barc); 1994 Apr; 102(12):456-7. PubMed ID: 8207994
[No Abstract] [Full Text] [Related]
47. [The clinical trial (II): ethics and legislation in Spain].
Pascual J; de Pablo López de Abechuco I; Gálvez MA; Hernández D
Nefrologia; 2005; 25(6):622-8. PubMed ID: 16514902
[No Abstract] [Full Text] [Related]
48. Conducting a European multi-center trial: first experiences with the new EU Clinical Trials Directive from an academic perspective.
Delawi D; Dhert WJ; Oner FC
Eur Spine J; 2008 Aug; 17(8):1113-5. PubMed ID: 18551324
[No Abstract] [Full Text] [Related]
49. [Comments of the new regulations concerning clinical trials].
García López FJ; Pijoán Zubizarreta JI
Med Clin (Barc); 1994 Nov; 103(15):587-90. PubMed ID: 7646621
[No Abstract] [Full Text] [Related]
50. Lessons learned from a clinical trial.
Armstrong PW; Newby LK; Granger CB; Lee KL; Simes RJ; Van de Werf F; White HD; Califf RM;
Circulation; 2004 Dec; 110(23):3610-4. PubMed ID: 15583090
[No Abstract] [Full Text] [Related]
51. A review finds that multicenter studies face substantial challenges but strategies exist to achieve Institutional Review Board approval.
Greene SM; Geiger AM
J Clin Epidemiol; 2006 Aug; 59(8):784-90. PubMed ID: 16828670
[TBL] [Abstract][Full Text] [Related]
52. Standardisation and harmonisation boost the credibility of nuclear medicine procedures.
Tatsch K
Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):186-7. PubMed ID: 22089662
[No Abstract] [Full Text] [Related]
53. Compliance with patient-reported outcomes in multicenter clinical trials: methodologic and practical approaches.
Land SR; Ritter MW; Costantino JP; Julian TB; Cronin WM; Haile SR; Wolmark N; Ganz PA
J Clin Oncol; 2007 Nov; 25(32):5113-20. PubMed ID: 17991930
[TBL] [Abstract][Full Text] [Related]
54. Re: Multicentre quality assurance of intensity-modulated radiation therapy planning: beware the benchmarker.
Williams MJ; Bailey MJ; Forstner D; Metcalfe PE
J Med Imaging Radiat Oncol; 2008 Jun; 52(3):303. PubMed ID: 18477127
[No Abstract] [Full Text] [Related]
55. [Clinical trials--historical development, regulation and updated data].
Tamir O; Shemer J
Harefuah; 2004 Mar; 143(3):232-5, 244. PubMed ID: 15065366
[TBL] [Abstract][Full Text] [Related]
56. An analysis of institutional effects in a multicenter cancer clinical trial: is it also plausible from the clinicians' point of view?
Sakamoto J; Matsuyama Y; Ohashi Y
Jpn J Clin Oncol; 1999 Aug; 29(8):403-5. PubMed ID: 10494927
[No Abstract] [Full Text] [Related]
57. A clinical trial in a developing country: many questions, few answers.
Kietinun S; Gupte MD; Sengupta A
Issues Med Ethics; 2003; 11(3):89-90. PubMed ID: 16335511
[No Abstract] [Full Text] [Related]
58. [Data and reflections on the current process of the multicenter clinical trial assessment in Spain].
Ortega Basagoiti R; Morejón Bosch E; Dal Ré R
Rev Clin Esp; 2006 Oct; 206(9):444-6. PubMed ID: 17042986
[TBL] [Abstract][Full Text] [Related]
59. A proposed revision to the ACR20: the hybrid measure of American College of Rheumatology response.
American College of Rheumatology Committee to Reevaluate Improvement Criteria
Arthritis Rheum; 2007 Mar; 57(2):193-202. PubMed ID: 17330293
[TBL] [Abstract][Full Text] [Related]
60. Multicenter trials versus observational databases.
Frame JN
Bone Marrow Transplant; 1991 Jul; 8(1):63-4. PubMed ID: 1912957
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
